Clinical Trials Browser

Phase 1 × disitamab vedotin × Gastrointestinal × Clear all

NCT06078982 2023-10-12

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Phase 1 Unknown

Gastrointestinal

Stomach Neoplasms